Pharmacological treatment of chronic heart failure

被引：0
作者：
Rachele Adorisio
Leonardo De Luca
Joseph Rossi
Mihai Gheorghiade
机构：
[1] Ospedale Bambino Gesù,Department of Cardiology and Cardiac Surgery
[2] European Hospital,Division of Cardiology
[3] Northwestern University,undefined
[4] Feinberg School of Medicine,undefined
[5] Northwestern University,undefined
[6] Feinberg School of Medicine,undefined
来源：
Heart Failure Reviews | 2006年 / 11卷
关键词：
Heart failure; Drugs; Angiotensin-converting enzyme inhibitors; β-blockers; Diuretics; Digitalis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Heart failure (HF) is associated with a high morbidity and mortality in the Western World. Our knowledge of the epidemiology, pathophysiology, and therapy has improved dramatically during the last 20 years. Pharmacological treatment, as it stands today, is a combination of preventive and symptomatic strategies. The mainstay life-saving drugs are angiotensin-converting enzyme inhibitors and β-blockers. Additional benefits are obtained when angiotensin-receptor blockers or aldosterone antagonists are added. Digitalis and/or diuretics are useful for symptom reduction. In addition, combination therapy with hydralazine and isosorbide dinitrate is recommended in African Americans.
引用
收藏
页码：109 / 123
页数：14
相关论文
共 496 条
  • [81] Brown EJ(1993)Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED Trial J Am Coll Cardiol 22 955-62
  • [82] Cuddy TE(1997)The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 525-33
  • [83] Davis BR(1997)Digitalis Investigation Group (DIG) trial: a stimulus for further research Am Heart J 134 3-12
  • [84] Geltman EM(2003)Association of serum digoxin concentration and outcomes in patients with heart failure JAMA 289 871-8
  • [85] Goldman S(1994)Effect of prolonged nitrate therapy on left ventricular remodeling after canine acute myocardial infarction Circulation 89 2297-2307
  • [86] Flaker GC(1991)Concurrent hydralazine administration prevents nitroglycerin- induced hemodynamic tolerance in experimental heart failure Circulation 84 35-9
  • [87] Kober L(1983)Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure Circulation 67 817-22
  • [88] Torp-Pedersen C(1987)Hemodynamic and volumetric effects of venodilation with nitroglycerin in chronic mitral regurgitation Am J Cardiol 60 1106-11
  • [89] Carlsen JE(1986)Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study N Engl J Med 314 1547-52
  • [90] Bagger H(1991)A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure N Engl J Med 325 303-10
45678910111213